Healthcare -
Biotechnology - NASDAQ - US
$ 42.5681
0.355 %
$ 11.6 B
Market Cap
19.26
P/E
EXEL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities EXEL - Exelixis, Inc.
-629 M
LAST VALUE
-3177.27%
2 YEAR CAGR
-119.62%
5 YEAR CAGR
-26.63%
10 YEAR CAGR